Next, by constructing a mutant of binding site 2 and co-transfecting lung adenocarcinoma cells with miR-1976, it was found that miR-1976 could not inhibit luciferase activity, thus further proving the binding of miR-1976 to NCAPH binding site 2. The gene discussed is NCAPH; the disease is lung adenocarcinoma.